THE IMPACT OF UNIVERSAL HEALTH INSURANCE COVERAGE ON USE OF MEDICINES FOR NON-COMMUNICABLE DISEASES IN THAILAND

Author(s)

Garabedian LF1, Ross-Degnan D1, Stephens P2, Ratanawijitrasin S3, Wagner A11Harvard Medical School, Boston, MA, USA, 2IMS Health Consulting Group, London, United Kingdom, 3Mahidol University, Salaya, NakornPathom, Thailand

OBJECTIVES:   In 2001, Thailand implemented the 30 Baht Scheme, a public insurance scheme that covers the poor and uninsured and pays providers through a capitated payment scheme.  Our objective is to evaluate the impact of the 30 Baht Scheme on use of medicines in Thailand for three non-communicable diseases: cancer, cardiovascular disease, and diabetes. METHODS: We used an interrupted time series design to measure the impact of the 30 Baht Scheme on total pharmaceutical market volume and market share.  We used IMS Health data on quarterly purchases of medicines from hospital and retail pharmacies from 1998 to 2006. RESULTS: The 30 Baht Scheme was associated with long-term increases in hospital sector sales of medicines for conditions that can be adequately treated in outpatient and primary care settings (e.g., diabetes, high cholesterol and high blood pressure).  The policy was associated with no change in sales of medicines for more life-threatening diseases, which are more appropriately treated in secondary or tertiary settings (e.g., myocardial infarction, stroke and cancer).  The majority of sales were for essential medicines, yet there were also post-policy increases for non-essential medicines.  Immediately following the reform, there was a significant shift in hospital sector market share by licensing status for most classes of medicines.  We observed large increases in government-produced products, primarily at the expense of branded generics. CONCLUSIONS: Our results suggest that expanding health insurance coverage with a medicines benefit to the entire Thai population increased the volume of medicine sales in primary care hospitals.  Our study, however, also suggests that implementation of the 30 Baht Scheme may have been associated with possibly undesirable effects:  increased use of non-essential medicines and decreased use of less expensive generics and medicines in secondary and tertiary settings.  Thorough evaluation of desired and undesired effects of universal health insurance programs are urgently needed.

Conference/Value in Health Info

2012-06, ISPOR 2012, Washington, D.C., USA

Value in Health, Vol. 15, No. 4 (June 2012)

Code

PCN120

Topic

Health Policy & Regulatory

Topic Subcategory

Pricing Policy & Schemes

Disease

Cardiovascular Disorders, Diabetes/Endocrine/Metabolic Disorders, Oncology, Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×